Evidence map›Paper›PMID 30900378›Full record

ReviewJournal of clinical hypertension (Greenwich, Conn.)2019

Orthostatic hypotension: From pathophysiology to clinical applications and therapeutic considerations.

Nikolaos Magkas, Costas Tsioufis, Costas Thomopoulos, Polychronis Dilaveris, Georgios Georgiopoulos, Elias Sanidas, Vasilios Papademetriou, Dimitrios Tousoulis

Abstract readReview
In one paragraph

Review in Journal of clinical hypertension (Greenwich, Conn.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Nikolaos MagkasFirst Department of Cardiology, "Hippokration" Hospital, University of Athens, Medical School, Athens, Greece.ORCID 0000-0003-1645-9716
Costas TsioufisFirst Department of Cardiology, "Hippokration" Hospital, University of Athens, Medical School, Athens, Greece.
Costas ThomopoulosDepartment of Cardiology, Helena Venizelou Hospital, Athens, Greece.ORCID 0000-0002-8491-6029
Polychronis DilaverisFirst Department of Cardiology, "Hippokration" Hospital, University of Athens, Medical School, Athens, Greece.
Georgios GeorgiopoulosFirst Department of Cardiology, "Hippokration" Hospital, University of Athens, Medical School, Athens, Greece.ORCID 0000-0001-7661-5253
Elias SanidasHypertension Excellence Centre-ESH, Department of Cardiology, LAIKO General Hospital, Athens, Greece.ORCID 0000-0002-2046-668X
Vasilios PapademetriouCardiology Department, Georgetown University and Veterans Affairs Medical Center, Washington, District of Columbia.ORCID 0000-0002-2882-2757
Dimitrios TousoulisFirst Department of Cardiology, "Hippokration" Hospital, University of Athens, Medical School, Athens, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Orthostatic hypotension (OH), that is blood pressure fall when standing from the supine to the erect position, is a common cardiovascular disorder, highly prevalent in elderly and frail individuals and in patients with multiple comorbidities. Orthostatic hypotension is considered a manifestation of dysfunction of the autonomic nervous system, caused or facilitated by several neurological or non-neurological diseases and conditions, while its clinical significance is increasingly recognized as a cause of impairment of quality of life and potentially of worse outcomes. Indeed, OH has been extensively studied and numerous prospective cohort studies support its association with adverse events, including coronary artery disease, heart failure, stroke, cognitive dysfunction, and, most importantly, mortality rates. Specific pharmacological and non-pharmacological interventions have been established for the treatment of OH. However, randomized data evaluating the impact of therapeutic interventions on morbidity and mortality outcomes are lacking. Thus, despite that OH seems to have important prognostic implications indicated by several reported associations with adverse events, it remains unclear whether OH treatment could improve prognosis. In the present review, we discuss the clinical applications associated with ΟΗ by outlining the current perspectives on ΟΗ definition, diagnosis, pathophysiology, prognostic role, and treatment.

Indexed as

AgedAged, 80 and overAutonomic Nervous SystemCognitive DysfunctionComorbidityCoronary Artery DiseaseHeart FailureHumansHypotension, OrthostaticMiddle AgedMortalityPrevalencePrognosisProspective StudiesQuality of LifeStrokeautonomic nervous systemblood pressurecardiovascular outcomesneurogenicorthostatic hypotension

Identifiers

PMID30900378
PMCPMC8030387

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.